Soritar30 gm

Soritar 30 gm is a topical combination preparation used for chronic scaling and inflammatory skin conditions. It combines a keratolytic/antipruritic tar, a keratolytic/mild antimicrobial sulphur component, and a keratolytic acid to soften and remove scale while reducing associated itching and inflammation.

Established/Commonly Accepted Uses

• Psoriasis (chronic plaque psoriasis of the scalp and body) - to reduce scaling, thickness, and itching of plaques, often as an adjunct to other antipsoriatic therapy.
• Seborrheic dermatitis of the scalp and skin - to control scaling, flaking, and mild inflammation.
• Dandruff (pityriasis capitis) - to reduce visible flaking and itching of the scalp.

Adjunct / Off-label Use

• Occasionally used as an adjunct keratolytic in mild acne vulgaris or other hyperkeratotic, scaling dermatoses, though this is not a primary approved indication and evidence is limited compared with dedicated acne therapies.

Soritar 30 gm is intended for topical use only and is not a cure; it manages symptoms and requires consistent, correct use as directed by a physician or pharmacist.

Soritar 30 gm is a fixed combination topical preparation typically formulated as an ointment, cream, lotion, gel, or medicated shampoo. Strengths and exact concentrations vary by manufacturer and dosage form; consult the specific product label for the precise percentage of each component in a given brand.

Soritar 30 gm is a combination antipsoriatic/keratolytic topical medicine. Coal tar has been used for over a century for chronic scaling skin disease because it slows abnormal, rapid turnover of skin cells and has mild anti-inflammatory and antipruritic effects. Precipitated sulphur is a keratolytic agent with mild antibacterial and antifungal activity that helps loosen and remove scale. Salicylic acid is a well-established keratolytic that softens the outer keratin layer of the skin, promoting shedding of scale and improving penetration of other topical agents.

Together, these three components are formulated to soften, loosen, and remove thickened, scaly skin while calming associated itching and mild inflammation in conditions such as psoriasis, seborrheic dermatitis, and dandruff. Soritar 30 gm is available in Bangladesh in topical dosage forms (e.g., ointment/shampoo) intended for external use only.

Soritar 30 gm belongs to the therapeutic class of topical antipsoriatics / keratolytic and antiseborrheic combination preparations used in dermatology.

Soritar 30 gm acts through three complementary mechanisms:

• Coal tar reduces epidermal DNA synthesis and abnormal keratinocyte hyperproliferation, normalizing the accelerated skin cell turnover seen in psoriasis; it also has mild anti-inflammatory and antipruritic properties.
• Precipitated sulphur exerts a keratolytic effect by breaking down keratin, and has mild antibacterial and antifungal activity that may help reduce surface microbial colonization contributing to scaling and irritation.
• Salicylic acid is a keratolytic that dissolves the intercellular cement of the stratum corneum, softening and loosening scale for easier removal and enhancing penetration of concurrently applied topical therapy.

Systemic absorption through intact skin is generally low with normal use, but salicylic acid can be absorbed systemically if applied over large body surface areas, under occlusion, or on broken/inflamed skin, particularly in children (see Use in Special Populations and Precautions).

For topical/external use only.

• Clean and dry the affected area before applying Soritar 30 gm.
• Apply a thin, even layer to the affected skin or scalp only; avoid normal surrounding skin where possible.
• For shampoo formulations, wet the hair and scalp, apply, massage gently, leave on for the time stated on the label, then rinse thoroughly.
• Wash hands thoroughly after application unless the hands are the treated area.
• Avoid contact with the eyes, lips, mouth, and other mucous membranes; rinse promptly with water if accidental contact occurs.
• Do not bandage or cover the treated area tightly (occlusive dressing) unless instructed by a physician, as this increases systemic absorption.
• Not for oral, ophthalmic, vaginal, or rectal use.

Formal drug-interaction studies with Soritar 30 gm are limited, as it is a topical preparation with generally low systemic absorption when used as directed. Clinically relevant considerations include:

• Other topical keratolytics or irritants (e.g., other salicylic acid, benzoyl peroxide, retinoid, or tar-containing products) - concurrent use on the same area may increase local irritation, dryness, and peeling; avoid combining unless directed by a physician.
• Photosensitizing agents/UV therapy - the coal tar component itself increases photosensitivity; combining with other photosensitizing drugs or phototherapy should be supervised by a physician to reduce the risk of exaggerated sunburn-like reactions.
• Other topical or systemic salicylates - concurrent extensive use of other salicylate-containing products may theoretically increase total salicylate absorption; use with caution, especially in children.

Most side effects of Soritar 30 gm are local and related to its keratolytic and tar components:

• Local skin irritation, redness, burning, or stinging at the site of application (common, especially early in treatment).
• Dryness, peeling, or mild contact dermatitis.
• Photosensitivity of treated skin (increased sunburn risk) due to the coal tar component.
• Staining of skin, hair, nails, clothing, and bedding (brownish discoloration) from the coal tar component.
• Strong, persistent odor characteristic of coal tar preparations.
• Folliculitis or acne-like eruptions with prolonged use in some individuals.
• Rarely, allergic contact dermatitis or hypersensitivity reactions.

Discontinue use and seek medical advice if severe irritation, blistering, or signs of allergic reaction occur.

Data on the use of Soritar 30 gm during pregnancy and lactation are limited. Topical salicylic acid and coal tar are absorbed systemically to only a small degree when used on limited areas of intact skin, but use over large areas, prolonged use, or use under occlusion increases systemic exposure. As a precaution, Soritar 30 gm should be used during pregnancy only if clearly needed and if the potential benefit justifies the potential risk to the fetus; a physician should be consulted before use.

It is not known whether topically applied components of Soritar 30 gm pass into breast milk in clinically significant amounts. Caution is advised during breastfeeding; avoid application to the breast/nipple area, and consult a physician before use.

Use Soritar 30 gm with the following precautions:

• For external use only; avoid contact with eyes, lips, and mucous membranes.
• The coal tar component increases skin photosensitivity - avoid excessive sun or UV (including tanning bed) exposure on treated areas, and use sun protection.
• Limit the treated body surface area and avoid occlusive dressings to reduce the risk of systemic salicylate absorption, particularly in children (see Use in Special Populations).
• Expect staining of skin, hair, and light-colored fabrics; protect clothing and bedding.
• Local irritation is common, especially with combined keratolytic and tar ingredients; if excessive redness, burning, or peeling occurs, reduce frequency or discontinue and consult a physician.
• Do not use on widespread areas of the body without medical guidance.
• Do not apply to acutely inflamed, broken, or infected skin unless directed by a physician (see Contraindications).
• Discontinue and seek medical advice if signs of hypersensitivity or worsening of the condition occur.

Overdose with Soritar 30 gm is unlikely with normal topical use but may occur with accidental ingestion or extensive application over large areas of broken skin. Excessive systemic salicylate absorption can cause salicylate toxicity, with symptoms such as nausea, vomiting, ringing in the ears (tinnitus), rapid breathing, confusion, or drowsiness. Accidental ingestion may cause gastrointestinal irritation, nausea, and vomiting.

If overdose, accidental ingestion, or signs of systemic toxicity are suspected, stop use immediately and seek immediate medical attention or contact a poison control center/emergency services. Do not attempt specific home treatment for suspected salicylate toxicity.

Store at room temperature (below 30°C), away from light and moisture. Keep out of reach of children. Keep the container tightly closed.

Pediatric Use

Soritar 30 gm should be used with caution in children. It is generally not recommended in infants and very young children (per product labeling, typically under 2 years of age) because their proportionally larger skin surface area increases the risk of systemic salicylate absorption and toxicity. In older children, use the smallest effective amount over the smallest area necessary, under medical supervision.

Elderly

No specific dose adjustment is generally required in elderly patients; however, elderly skin may be more fragile and prone to irritation, so treated areas should be monitored closely.

Renal/Hepatic Impairment

No well-established dose adjustment is required for topical use in renal or hepatic impairment, as systemic absorption is normally minimal; however, caution is advised if used over large areas, since increased systemic salicylate exposure could be relevant in significant renal impairment.

Duration of treatment with Soritar 30 gm depends on the condition being treated and response to therapy. Dandruff and mild seborrheic dermatitis may improve within a few weeks of regular use, while chronic conditions such as psoriasis often require longer, intermittent, or maintenance courses under medical supervision. Do not use continuously for prolonged periods without periodic reassessment by a physician, and discontinue if irritation or adverse effects occur.

Topical antipsoriatic; keratolytic; antiseborrheic combination agent (coal tar + sulphur + salicylic acid).

Soritar 30 gm works through combined keratolytic, antiproliferative, and mild antimicrobial actions: coal tar slows excessive epidermal cell turnover and reduces scaling and itching; precipitated sulphur loosens keratin and provides mild antibacterial/antifungal activity; salicylic acid softens and dissolves the intercellular matrix of the stratum corneum, promoting shedding of scale and improving penetration of the other active ingredients into affected skin.

Soritar 30 gm is generally not recommended for use in infants and young children (typically under 2 years of age per product labeling) due to the risk of increased percutaneous salicylate absorption from their proportionally greater skin surface area, which can lead to systemic salicylate toxicity. In older children, safety and efficacy have not been as extensively established as in adults; if used, it should be under medical supervision, applied to the smallest area necessary, for the shortest effective duration, avoiding occlusive dressings.